Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation

Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation

The primary objectives of this study are:

• To estimate the incidence rate of unexpected adverse events
• To characterize the bleeding events and assess risk factors of bleeding
• To identify ancillary baseline variables that may also be associated with adverse outcomes

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.

Inclusion Criteria:

• Patients who are beginning to receive the treatment with this product under the approved indications, dosage, and administration will be included in this study

Exclusion Criteria:

• Patients who are receiving Eliquis outside of its approved indication will be excluded from this study